Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30

Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30–65 years

Published:2017-11-09 Issue:1 Volume:29 Page:43-50
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Silver Michelle I.^ORCID,Rositch Anne F.,Phelan-Emrick Darcy F.,Gravitt Patti E.

Funder

Agency for Healthcare Research and Quality

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10552-017-0976-x/fulltext.html

Reference44 articles.

1. Howlader NNA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review, (1975–2011), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/ , based on November 2013 SEER data submission, posted to the SEER web site, April 2014. 2014

2. CDC (2012) behavioral risk factor surveillane system survey data. In. Edited by Services DoHaH. Atlanta: Centers for Disease Control and Prevention

3. Phelan DF, Boitnott J, Clark DP, Dubay L, Gravitt P (2011) Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory. Obstetrics Gynecol 118(2):289–295

4. Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP (2012) Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 138(2):223–229

5. Bekker JB, John TS, Leiman G (2013) Confirming suboptimal adherence to hpv cotesting guidelines in an academic center in Vermont. Am J Clin Pathol 139(2):259–260

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems;Preventive Medicine Reports;2023-10

2. Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening;Cancer Prevention Research;2023-05-20

3. Use Trends and Recent Expenditures for Cervical Cancer Screening–Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years;JAMA Internal Medicine;2023-01-01

4. Trends and Racial/Ethnic Differences in Predictors of Cervical Cancer Screening among US Women Ages 30–64 Years;Cancer Epidemiology, Biomarkers & Prevention;2022-10-28

5. Cervical cancer screening in high-altitude areas in China: A large cross-section study of 25,173 women in northern Tibet;Frontiers in Oncology;2022-08-25